Materialise Launches Mimics Innovation Suite for 3-D Medical Image Printing

June 3, 2015 - Celebrating its 25th anniversary, Materialise announces the launch of the latest Mimics Innovation Suite, including the Mimics 18.0 and 3-matic 10.0 software solutions. The new and improved tools increase user-friendliness, reduce segmentation time and make design and modeling even more realistic. It's also possible to 3-D print the results in full color. In addition, the visualization capabilities have been expanded with a fluoroscopy view and virtual X-ray simulation.

The Mimics Innovation Suite offers a complete set of tools developed for biomedical professionals. With the addition of the "˜Fluoroscopy View', healthcare professionals can simulate the angiographic view they would have during surgery and identify optimal C-arm angles for fluoroscopy for their region of interest.

A second new visualization option is the "˜Virtual X-ray' tool, which allows engineers to create virtual X-rays of projects to find the optimal angle for 2-D/3-D registration. This allows for an evaluation of the 3-D position of bones and implants without a post-operative computed tomography (CT) or magnetic resonance imaging (MRI) scan.

Another time-saving tool is the automated "˜Heart Segmentation'. This flexible, user-friendly solution allows for an effortless segmentation of the cardiovascular anatomy for advanced research and analyses. On a good quality dataset, segmentation now requires only a few mouse clicks rather than several hours of tedious work. In addition, the "˜Loft' and "˜Sweep Loft' tools make it easy to design benchtop models. With the advanced export options, it is now possible to add a logo to the design in only a few seconds and export it in *zpr format for 3-D printing in multiple colors.

Apart from software improvements, a new way to characterize the mitral valve has been added to the Mimics Innovation Suite. This new patent-pending workflow allows for a detailed analysis of this complex anatomy, reduces the number of design iterations needed and permits more confident entry into clinical trials.

For more information: www.materialise.com